Cardiovascular System Flashcards
ACE inhibitors prototype and other drug names
captopril (Capoten), lisinopril, enalopril, ramipril
ACE inhibitors EPA
block enzyme that converts angiotensin I to angiotensin II thereby decreasing vasoconstriction and aldosterone (reducing retention of sodium and water), leading to vasodilation and retention of K+
ACE inhibitors adminitstration
PO
ACE inhibitors therapeutic use
treatment of HTN and heart failure
ACE inhibitors ADRs
orthostatic hypotension, dry non productive cough, hyperkalemia, angioedema, taste distortions, rash
ACE inhibitors contraindications and interactions
Pregnancy - teratogenic
Breastfeeding
Liver disease w/elevated liver enzymes
Avoid NSAIDs
ACE inhibitors RN intervention and client education
Avoid salt substitutes
Monitor BP before, during, and after
Educate patient regarding possibility of chronic, dry, unproductive cough
Monitor K+ due to potential for hyperkalemia
Potassium levels - 3.5-5
ARBs prototype and other drug name
losartan (Cozaar), valsartan (Diovan), and irbesartan (Avapro)
ARBs EPA
blocks vasoconstricting and aldosterone-secreting effects of angiotensin II. Increases renal blood flow. Vasodilation and retention of K+
ARBs administration
PO
ARBs therapeutic use
treatment of HTN; stroke prevention (losartan only); diabetic neuropathy (Losartan and Irbesartan); heart failure (vasartan)
ARBs ADRs
angioedema, dizziness, hypotension, headache, insomnia
ARBs contraindications and interactions
Pregnancy /breast feeding - teratogenic
Children <6
NSAIDs increase risk for renal complications
ARBs RN intervention and client education
Monitor BP before, during, after
Monitor K+ due to potential for hyperkalemia (much less risk than w/ACE)
Monitor for angioedema
aldosterone antagonists prototype and other drug names
eplerenone (Inspra)
Others: spironolactone (Aldactone)
aldosterone antagonists EPA
blocks aldosterone receptors thereby blocking effects of aldosterone - excretion of Na+, water and retention of K+
aldosterone antagonists administration
PO can take up to 4 weeks
aldosterone antagonists therapeutic uses
HTN and symptoms of heart failure following MI
aldosterone antagonists ADRs
hyperkalemia (very common)
aldosterone antagonists contraindications and interactions
Avoid medications that can raise potassium such as ACE inhibitors, potassium sparing diuretics
Do not take if serum K+ levels are >/=5.0 mEq/L
Avoid if breastfeeding
Use caution in children
NSAIDs may decrease effects
If client is also taking lithium, aldosterone MAY cause lithium toxicity
aldosterone antagonists RN intervention and client education
Monitor BP
Monitor for s/sx of hyperkalemia:
- Palpitations, muscle twitching, weakness, paresthesia in extremities, diarrhea
- Slow irregular heart rate
Periodic blood levels:
- Potassium (K+)
- BUN and serum creatinine
Avoid salt substitutes
direct renin inhibitors prototype
aliksiren (Tekturna)
direct renin inhibitors EPA
binds with renin thereby inhibiting activation of angiotensin I - vasodilation and urinary excretion of sodium and water
direct renin inhibitors administration
PO 1 hour before meals. Do not admin w/ fatty foods (decreases absorption). 2 weeks to reach therapeutic effect
direct renin inhibitors therapeutic use
HTN
direct renin inhibitors ADRs
diarrhea, dyspepsia, abdominal pain; low incidence of hyperkalemia, but still possible; angioedema; dry nonproductive cough similar to ACE but not as common
direct renin inhibitors contraindications and interactions
Pregnancy and lactation
Hyperkalemia (K+ > 5.0 mEq/L)
<18 year old
ACE inhibitors and ARBs
Increases blood levels of atorvastatin (Lipitor)
direct renin inhibitors RN interventions and client education
Monitor BP
Monitor for s/sx of hyperkalemia:
- Palpitations, muscle twitching, weakness, paresthesia in extremities, diarrhea
- Slow irregular heart rate
Periodic blood levels:
- Potassium (K+)
- BUN and serum creatinine
Avoid salt substitutes
Calcium channel blockers (CCB) prototype and other drug names
nifedipine (Adalat) or (Procardia)
Others: amlodipine (Norvasc), verapamil (Calan), diltiazem (Cardizem)
CCB EPA
block calcium channels in vascular smooth muscle cells of peripheral arteries - vasodilation and decreased BP
CCB administration
PO (IR or ER)
CCB therapeutic use
HTN; stable angina
CCB ADRs
reflex tachycardia, angina: vasodilatory effects: headache, dizziness, facial flushing, peripheral edema and arrhythmias. Gingival hyperplasia
CCB contraindications and interactions
Avoid in children
2nd and 3rd degree heart block
Many drug interactions (anti seizure meds)
Grapefruit juice increases blood levels
CCB RN interventions and client education
Monitor BP and heart rate. HOLD for SBP <90
Instruct client to periodically measure HR and BP
Risk for falls
Monitor for peripheral edema (diuretic)
Regular dental checkups
Avoid grapefruit juice and grapefruit
alpha 1 blockers prototype and other drug names
Prototype: doxazosin (Cardura)
Others: prazosin (Minipress)
alpha 1 blockers EPA
block alpha1 receptors - venous and arteriolar dilation
alpha 1 blockers administration
PO at bedtime
alpha 1 blockers therapeutic use
HTN and benign prostatic hypertrophy (BPH)
alpha 1 blockers ADRs
orthostatic hypotension; reflex tachycardia, headache, dizziness
alpha 1 blockers contraindications and interaction
Avoid in children
Liver disease
CONTRAINDICATED in sildenafil (Viagra)
alpha 1 blockers RN intervention and client education
Carefully monitor BP when changing positions
Risk for falls secondary to orthostatic changes
Raise slowly from sitting to standing
beta blockers prototype and other drug names
atenolol (Tenformin)
Others: metoprolol (Lopressor), carvedilol (Coreg)
beta blockers EPA
block beta1 receptors - dec in HR and contractility - cardiac output and suppresses reflex tachycardia. Block beta 1 in kidney - blocks renin release
beta blockers administration
PO (IR and ER) and IV
beta blockers therapeutic use
HTN, angina, dysrhythmias, MI, heart failure
beta blockers ADRs
bradycardia, heart failure, rebound excitation with sudden withdrawal
beta blockers contraindications and interactions
Bradycardia
1st degree heart block
Heart failure
Children <6
Asthma or COPD
May inc effects of oral hypoglycemia agents
beta blockers RN intervention and client education
Carefully monitor BP and HR
HOLD for SBP < 90 and HR < 60
Do not stop abruptly
Monitor for s/sx of heart failure: SOB, edema, coughing at night while orthopneic
direct acting vasodilators prototype
hydralizine
direct acting vasodilators EPA
acts directly on arterioles to relax smooth muscle leading to vasodilation. stimulates SNS, affecting heart rate
direct acting vasodilators administration
PO and IV
direct acting vasodilators therapeutic use
mod - severe HTN, hypertensive crisis
direct acting vasodilators ADRs
reflex tachycardia, dizziness, fluid retention
direct acting vasodilators RN intervention and client education
Monitor BP prior to, during, and after administration
Do not stop abruptly
cardiac glycoside prototype
digoxin (Lanoxin)
cardiac glycoside therapeutic use
management of mild to moderate heart failure in adults and children. The drug is also used to control the ventricular response rate in adults with chronic arterial fibrillation
cardiac glycoside administration
PO and IV
cardiac glycoside EPA
positive inotropic effect that improves the contractility and pumping ability of the heart. Increases the force of myocardial contractility by inhibiting NA, K, ATPase (increased calcium = increased contraction)